Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.648
-0.002 (-0.37%)
At close: Sep 6, 2024, 4:00 PM
0.641
-0.007 (-1.02%)
After-hours: Sep 6, 2024, 5:26 PM EDT
Bolt Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 6.2 | 10.81 | 9.24 | 27.38 | 5.54 | 34.83 | Upgrade
|
| Short-Term Investments | 67.5 | 91.38 | 159.64 | 158.84 | 17.3 | - | Upgrade
|
| Cash & Short-Term Investments | 73.7 | 102.19 | 168.89 | 186.22 | 22.84 | 34.83 | Upgrade
|
| Cash Growth | -41.45% | -39.49% | -9.31% | 715.39% | -34.42% | 155.43% | Upgrade
|
| Other Receivables | 0.2 | 1.3 | - | - | - | 0.3 | Upgrade
|
| Receivables | 0.2 | 1.3 | - | - | - | 0.3 | Upgrade
|
| Prepaid Expenses | 2.73 | 2.04 | 3.86 | 2.94 | 2.52 | 0.77 | Upgrade
|
| Other Current Assets | - | 0.18 | - | - | - | - | Upgrade
|
| Total Current Assets | 76.63 | 105.71 | 172.75 | 189.16 | 25.36 | 35.9 | Upgrade
|
| Property, Plant & Equipment | 21.64 | 24.08 | 28.53 | 30.6 | 16.35 | 11.52 | Upgrade
|
| Long-Term Investments | 23.83 | 26.41 | 23.94 | 85.35 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | 0.37 | - | - | 2.36 | - | Upgrade
|
| Other Long-Term Assets | 2.07 | 3.22 | 2.59 | 2.61 | 2.47 | 1.03 | Upgrade
|
| Total Assets | 124.18 | 159.78 | 227.81 | 307.72 | 46.54 | 48.45 | Upgrade
|
| Accounts Payable | 2.63 | 2.99 | 3.59 | 3.57 | 1.6 | 2.1 | Upgrade
|
| Accrued Expenses | 7.35 | 12.49 | 15.14 | 12.38 | 6.66 | 2.87 | Upgrade
|
| Current Portion of Leases | 3 | 2.78 | 2.39 | 2.5 | 1.5 | 3.1 | Upgrade
|
| Current Unearned Revenue | 2.02 | 2.2 | 1.99 | 2.87 | 1.5 | 0.6 | Upgrade
|
| Total Current Liabilities | 17.9 | 20.46 | 23.12 | 21.33 | 11.26 | 8.66 | Upgrade
|
| Long-Term Leases | 15.9 | 17.44 | 20.22 | 21.85 | 9.38 | 7.09 | Upgrade
|
| Long-Term Unearned Revenue | 4.52 | 9.11 | 12.92 | 14.21 | - | 0.97 | Upgrade
|
| Other Long-Term Liabilities | - | 0.04 | 0.04 | 0.21 | 0.33 | 0.07 | Upgrade
|
| Total Liabilities | 38.32 | 47.04 | 56.3 | 57.6 | 20.97 | 16.79 | Upgrade
|
| Common Stock | 0 | 0 | - | - | - | - | Upgrade
|
| Additional Paid-In Capital | 482.19 | 476.99 | 467.51 | 457.43 | 3.45 | 1.83 | Upgrade
|
| Retained Earnings | -396.29 | -364.29 | -295.09 | -206.99 | -108.4 | -47.67 | Upgrade
|
| Comprensive Income & Other | -0.04 | 0.04 | -0.92 | -0.32 | - | - | Upgrade
|
| Total Common Equity | 85.86 | 112.74 | 171.51 | 250.12 | -104.95 | -45.85 | Upgrade
|
| Shareholders' Equity | 85.86 | 112.74 | 171.51 | 250.12 | 25.57 | 31.66 | Upgrade
|
| Total Liabilities & Equity | 124.18 | 159.78 | 227.81 | 307.72 | 46.54 | 48.45 | Upgrade
|
| Total Debt | 18.89 | 20.22 | 22.61 | 24.36 | 10.88 | 10.19 | Upgrade
|
| Net Cash (Debt) | 54.81 | 81.97 | 146.28 | 161.86 | 11.96 | 24.64 | Upgrade
|
| Net Cash Growth | -47.50% | -43.96% | -9.63% | 1253.26% | -51.46% | 81.26% | Upgrade
|
| Net Cash Per Share | 1.44 | 2.17 | 3.92 | 4.88 | 5.69 | 12.36 | Upgrade
|
| Filing Date Shares Outstanding | 38.26 | 38.13 | 37.81 | 37.47 | 36.33 | 1.92 | Upgrade
|
| Total Common Shares Outstanding | 38.26 | 38.11 | 37.8 | 37.4 | 2.13 | 1.92 | Upgrade
|
| Working Capital | 58.73 | 85.25 | 149.63 | 167.83 | 14.1 | 27.24 | Upgrade
|
| Book Value Per Share | 2.24 | 2.96 | 4.54 | 6.69 | -49.27 | -23.86 | Upgrade
|
| Tangible Book Value | 85.86 | 112.74 | 171.51 | 250.12 | -104.95 | -45.85 | Upgrade
|
| Tangible Book Value Per Share | 2.24 | 2.96 | 4.54 | 6.69 | -49.27 | -23.86 | Upgrade
|
| Machinery | 10.46 | 10.42 | 10.1 | 8.26 | 5.32 | 2.03 | Upgrade
|
| Leasehold Improvements | 0.29 | 0.29 | 0.27 | 0.15 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.